GRACE :: Kidney Cancer

Late Stage RCC

GRACE Video

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

Share

Cancer Grace ASCO 2015 - Video 01-HD

 

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.

 


GRACE Video

Cabozantinib for Late Stage Kidney Cancer

Share

Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.


GRACE Video

How is the Heng Criteria Applied to Kidney Cancer Patients?

Share

Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.


GRACE Video

Treating Newly Diagnosed Kidney Cancer

Share

Dr. Guru Sonpavde discusses what he does when he first begins treating a patient recently diagnosed with late stage kidney cancer.


GRACE Video

The Hottest Thing in Late Stage Kidney Cancer

Share

Patients are responding very well to the next generation of immunotherapy drugs currently in clinical trials to treat kidney cancer.


Ask Us, Q&A
Kidney Cancer Expert Content

Archives

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243